↓ Skip to main content

Famitinib in combination with concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 1, open‐label, dose‐escalation Study

Overview of attention for article published in this source, November 2018
Altmetric Badge

Mentioned by

googleplus
1 Google+ user

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
51 Mendeley